Top

International Journal of Diabetes in Developing Countries

Published in:

01-04-2020 | Insulins | Original Article

Association of adiponectin gene polymorphisms and their haplotypes with type 2 diabetes and related metabolic traits in an Iranian population

Authors: Hamid Reza Joshaghani, Parviz Kokhaei, Mehdi Barati, Abbas Pakdel, Ghorban Mohammadzadeh, Navid Bandegi, Ahmad Reza Bandegi

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2020

Abstract

Introduction

Adiponectin is an adipocyte-secreted protein that contributes to glucose homeostasis. Contradictory reports are available on single nucleotide polymorphisms (SNPs) in the adiponectin gene and the risk of type 2 diabetes (T2D). We investigate the association of adiponectin gene SNPs (+45T/G and +276G/T) with serum adiponectin, insulin resistance, lipid profile, and T2D risk in an Iranian population.

Method

The +45T/G and +276G/T SNPs were genotyped in 211 non-familial T2D patients and 202 non-diabetic subjects by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and TaqMan probe, respectively.

Results

T2D was associated with a decrease in serum adiponectin level. The G allele and the GG and TG genotypes of +45T/G SNP were more abundant than the T allele and the TT genotype in T2D patients compared with controls (p < 0.001). The risk of T2D in individuals with the GG and TG genotypes of +45T/G SNP was 4 and 2 times more than that with the TT genotype, respectively. There was no statistically significant difference in the frequencies of allele and genotype of +276G/T SNP between the control and T2D groups. The presence of +45G/+276G haplotype was associated with an increased risk of T2D (OR = 2.01, 95% CI = 1.34–3.03, p = 0.04).

Conclusion

Therefore, our results showed that +45T/G SNP is associated with the risk of T2D higher than +276G/T SNP in the studied population.

Costa AF, Flor LS, Campos MR, Oliveira AF, Costa MF, Silva RS, et al. Burden of type 2 diabetes mellitus in Brazil. Cadernos de Saude Publica. 2017;33(2):e00197915. https://doi.org/10.1590/0102-311x00197915.CrossRefPubMed

Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, et al. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health. 2017;17(1):133. https://doi.org/10.1186/s12889-016-3999-4.CrossRefPubMedPubMedCentral

Dendup T, Feng X, Clingan S, Astell-Burt T. Environmental risk factors for developing type 2 diabetes mellitus: a systematic review. Int J Environ Res Public Health. 2018;15(1). https://doi.org/10.3390/ijerph15010078.

Ali O. Genetics of type 2 diabetes. World J Diabetes. 2013;4(4):114–23. https://doi.org/10.4239/wjd.v4.i4.114.CrossRefPubMedPubMedCentral

Ma RC, Hu C, Tam CH, Zhang R, Kwan P, Leung TF, et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia. 2013;56(6):1291–305. https://doi.org/10.1007/s00125-013-2874-4.CrossRefPubMedPubMedCentral

Lee JK, Kim K, Ahn Y, Yang M, Lee JE. Habitual coffee intake, genetic polymorphisms, and type 2 diabetes. Eur J Endocrinol. 2015;172(5):595–601. https://doi.org/10.1530/eje-14-0805.CrossRefPubMed

Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90. https://doi.org/10.1038/ng.2383.CrossRefPubMedPubMedCentral

Breitfeld J, Stumvoll M, Kovacs P. Genetics of adiponectin. Biochimie. 2012;94(10):2157–63. https://doi.org/10.1016/j.biochi.2012.03.004.CrossRefPubMed

Yao M, Wu Y, Fang Q, Sun L, Li T, Qiao H. Association of ADIPOQ variants with type 2 diabetes mellitus susceptibility in ethnic Han Chinese from northeast China. J Diabetes Invest. 2016;7(6):853–9. https://doi.org/10.1111/jdi.12535.CrossRef

10.

Payab M, Amoli MM, Qorbani M, Hasani-Ranjbar S. Adiponectin gene variants and abdominal obesity in an Iranian population. Eating Weight Disord. 2017;22(1):85–90. https://doi.org/10.1007/s40519-016-0252-1.CrossRef

11.

Ji MJ, Ku EJ, Oh TK, Jeon HJ. Association of Adiponectin 45T/G polymorphism with diabetic cardiovascular complications in Korean type 2 diabetes. J Korean Med Sci. 2018;33(17):e124. https://doi.org/10.3346/jkms.2018.33.e124.CrossRefPubMedPubMedCentral

12.

Tu Y, Yu Q, Fan G, Yang P, Lai Q, Yang F, et al. Assessment of type 2 diabetes risk conferred by SNPs rs2241766 and rs1501299 in the ADIPOQ gene, a case/control study combined with meta-analyses. Mol Cell Endocrinol. 2014;396(1–2):1–9. https://doi.org/10.1016/j.mce.2014.08.006.CrossRefPubMed

13.

Motawi T, Salman T, Shaker O, Abdelhamid A. Association of polymorphism in adiponectin (+45T/G) and leptin (-2548 G/A) genes with type 2 diabetes mellitus in male Egyptians. Arch Med Sci. 2015;11(5):937–44. https://doi.org/10.5114/aoms.2015.54848.CrossRefPubMedPubMedCentral

14.

Kaftan AN, Hussain MK. Association of adiponectin gene polymorphism rs266729 with type two diabetes mellitus in Iraqi population. A pilot study. Gene. 2015;570(1):95–9. https://doi.org/10.1016/j.gene.2015.06.004.CrossRefPubMed

15.

Kacso IM, Farcas MF, Pop IV, Bondor CI, Potra AR, Moldovan D, et al. 276G>T polymorphism of the ADIPOQ gene influences plasma adiponectin in type 2 diabetes patients but is not predictive for presence of type 2 diabetes in a Caucasian cohort from Romania. Maedica. 2012;7(4):271–6.PubMedPubMedCentral

16.

Szopa M, Malczewska-Malec M, Kiec-Wilk B, Skupien J, Wolkow P, Malecki MT, et al. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol. 2009;46(4):317–22. https://doi.org/10.1007/s00592-008-0091-2.CrossRefPubMed

17.

Tabatabaei-Malazy O, Hasani-Ranjbar S, Amoli MM, Heshmat R, Sajadi M, Derakhshan R, et al. Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index. Rev Diabetic Stud. 2010;7(3):241–6. https://doi.org/10.1900/rds.2010.7.241.CrossRefPubMedPubMedCentral

18.

Mohammadzadeh G, Zarghami N. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand J Clin Lab Invest. 2009;69(7):764–71. https://doi.org/10.3109/00365510903137237.CrossRefPubMed

19.

Zhang L, Qin Y, Liang D, Li L, Liang Y, Chen L, et al. Association of polymorphisms in LEPR with type 2 diabetes and related metabolic traits in a Chinese population. Lipids Health Dis. 2018;17(1):2. https://doi.org/10.1186/s12944-017-0644-x.CrossRefPubMedPubMedCentral

20.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. https://doi.org/10.1007/bf00280883.CrossRefPubMed

21.

Sabouri S, Ghayour-Mobarhan M, Moohebati M, Hassani M, Kassaeian J, Tatari F, et al. Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population. TheScientificWorldJournal. 2011;11:93–101. https://doi.org/10.1100/tsw.2011.3.CrossRefPubMedPubMedCentral

22.

Tsai MK, Wang HM, Shiang JC, Chen IH, Wang CC, Shiao YF, et al. Sequence variants of ADIPOQ and association with type 2 diabetes mellitus in Taiwan Chinese Han population. TheScientificWorldJournal. 2014;2014:650393. https://doi.org/10.1155/2014/650393.CrossRefPubMedPubMedCentral

23.

Hussain MK, Deli FA, Algenabi AHA, Abdul-Rudha KH. Adiponectin gene polymorphisms as a predictor for development of type 2 diabetes mellitus in Iraqi population. Gene. 2018;662:118–22. https://doi.org/10.1016/j.gene.2018.03.087.CrossRefPubMed

24.

Biswas D, Vettriselvi V, Choudhury J, Jothimalar R. Adiponectin gene polymorphism and its association with type 2 diabetes mellitus. Indian J Clin Biochem. 2011;26(2):172–7. https://doi.org/10.1007/s12291-011-0123-5.CrossRefPubMedPubMedCentral

25.

Han LY, Wu QH, Jiao ML, Hao YH, Liang LB, Gao LJ, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, −11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia. 2011;54(9):2303–14. https://doi.org/10.1007/s00125-011-2202-9.CrossRefPubMed

26.

Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, et al. Genetic association study of adiponectin polymorphisms with risk of type 2 diabetes mellitus in Korean population. Diabetic Med J Br Diabetic Assoc. 2005;22(5):569–75. https://doi.org/10.1111/j.1464-5491.2005.01460.x.CrossRef

27.

Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet. 2002;11(21):2607–14.CrossRefPubMed

28.

Mohammadzadeh G, Ghaffari MA, Heibar H, Bazyar M. Association of two common single nucleotide polymorphisms (+45T/G and +276G/T) of ADIPOQ gene with coronary artery disease in type 2 diabetic patients. Iran Biomed J. 2016;20(3):152–60.PubMedPubMedCentral

29.

Yang WS, Chuang LM. Human genetics of adiponectin in the metabolic syndrome. J Mol Med (Berlin, Germany). 2006;84(2):112–21. https://doi.org/10.1007/s00109-005-0011-7.CrossRef

Title: Association of adiponectin gene polymorphisms and their haplotypes with type 2 diabetes and related metabolic traits in an Iranian population
Authors: Hamid Reza Joshaghani
Parviz Kokhaei
Mehdi Barati
Abbas Pakdel
Ghorban Mohammadzadeh
Navid Bandegi
Ahmad Reza Bandegi
Publication date: 01-04-2020
Publisher: Springer India
Keywords: Insulins
Insulins
Type 2 Diabetes
Published in: International Journal of Diabetes in Developing Countries / Issue 2/2020
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-019-00785-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2020

Blockade of receptor for advanced glycation end products improved essential response of inflammation in diabetic wound healing

Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: a cross-sectional study from a tertiary care institute in North India

Association of Cornell product with metabolic syndrome in middle-aged people in China

High-fat diet with alcohol elevate oxidative stress which cause hyperlipidemia by inducing mutation in the ANGPTL3 locus

Liver iron concentration is an independent risk factor for the prediabetic state in β-thalassemia patients

MACF1 gene variant rs2296172 is associated with T2D susceptibility in Mizo population from Northeast India

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials